Buys
Open market- Shares
- +1,000
- Avg price
- $13.26
- Total value
- +$13,260
Kyle Carver - Chief Financial Officer at Evommune, Inc.
Issuer-level insider activity
- Role
- Chief Financial Officer
- Issuer ticker
- EVMN on NYSE
- Entity type
- Individual
- Source filing history
- Open source filing history
Identity
Names, identifiers, and filing context for this profile.
1 identity field
Source evidence
Original filing metadata and source links for verification.
1 source field
Past-year transaction volume for Kyle Carver in Evommune, Inc.
Sells
Open market- Shares
- -18,175
- Avg price
- $22.84
- Total value
- -$415,117
Net
Past year- Shares
- -17,175
- Share %
- -90%
- Total value
- -$401,857
Reported holdings for Kyle Carver in Evommune, Inc.
Form 4 holding
Chief Financial Officer
Evommune, Inc.
- Security class
- Common Stock
- Shares / value
- 60,335
- Estimated value
- $800,042
- Report date
- 08 Jul 2026
- Price
- $13.26
- Ownership
- Direct
Form 4 holding
Chief Financial Officer
Evommune, Inc.
- Security class
- Employee Stock Option (Right to Buy)
- Shares / value
- 96,731
- Estimated value
- Report date
- 28 May 2026
- Price
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
Form 4 holding
Chief Financial Officer
Evommune, Inc.
- Security class
- Series B Preferred Stock
- Shares / value
- 0
- Estimated value
- Report date
- 07 Nov 2025
- Price
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
Transaction history for Kyle Carver in Evommune, Inc.
| Sym | Class | Transaction | % | SEC-reported value | SEC-reported price | Shares | Shares after | Date | Ownership |
|---|
* marks a reported price that did not pass the local price check.